Drug Excipient Business Development Reports now Available on Amazon
Drug Patent Watch
FEBRUARY 15, 2024
Elevate your excipient business strategies with the comprehensive Drug Excipient Business Development Reports from DrugPatentWatch.
Business Development Related Topics 
Pfizer hires Citi analyst Andrew Baum to manage portfolio strategy, business development
Fierce Pharma
MAY 6, 2024
In the role, he'll oversee the drugmaker's portfolio management and business development activities. .” | Citi analyst Andrew Baum, after covering Pfizer for more than a decade, will join the Big Pharma company as chief strategy and innovation officer.
Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Teva CEO Francis poaches business development head Angus Grant from BeiGene
Fierce Pharma
JULY 28, 2023
Teva’s CEO Richard Francis is adding to his constellation of new executives with a fresh business development hire from BeiGene. as its EVP of business development, the Israeli-American generics giant announced Friday. Teva has enlisted BeiGene's Angus Grant, Ph.D,
Key Business Development Skills Every Manager Should Have
BioSpace
JUNE 14, 2021
People working on business development are the ones responsible for dealing with the business side of the organization. Dealing with a lot of people, clients and a huge team is part of this job.
Divya Iyer, VP Strategy & Business Development at GoodRx, showcases digital health innovations at Digital Pharma East conference
Fierce Pharma
NOVEMBER 10, 2022
Divya Iyer, VP Strategy & Business Development at GoodRx, showcases digital health innovations at Digital Pharma East conference. Thu, 11/10/2022 - 13:14.
Mainz Biomed Appoints Steve Quinn as VP Business Development
BioTech 365
JANUARY 27, 2022
Mainz Biomed Appoints Steve Quinn as VP Business Development Mainz Biomed Appoints Steve Quinn as VP Business Development Highly experienced diagnostics business development executive appointed to lead growth initiatives across international markets and drive international sales of ColoAlert at-home screening … Continue reading →
PharmaSGP: Expected business development in Q1 2021
BioTech 365
MAY 17, 2021
PharmaSGP: Expected business development in Q1 2021 Group revenues of € 12.4 DGAP-News: PharmaSGP Holding SE / Key word(s): Quarterly / Interim Statement 18.05.2021 / 07:30 The issuer is solely responsible for the content of this announcement. million and adjusted … Continue reading →
Customer Success: Law Firm Business Development
Drug Patent Watch
NOVEMBER 18, 2019
DrugPatentWatch has deep resources to support patent prosecution and patent litigation, but it is also used by law firms for business development. The post Customer Success: Law Firm Business Development appeared first on DrugPatentWatch - Make Better Decisions. Find weak claims One of the first tweaks….
I-MED Pharma USA Announces Michelle Schnabel as VP Business Development
BioTech 365
NOVEMBER 9, 2021
I-MED Pharma USA Announces Michelle Schnabel as VP Business Development I-MED Pharma USA Announces Michelle Schnabel as VP Business Development MONTREAL, Nov. 09, 2021 (GLOBE NEWSWIRE) — With the recent expansion into the United States, I-MED Pharma USA is proud to announce … Continue reading →
eClinical Provider Crucial Data Solutions Appoints Brian Dufresne as SVP Business Development
Crucial Data Soutions
JUNE 27, 2022
Reno, NV, June 27, 2022 — Crucial Data Solutions (CDS), a provider of innovative low-code/no-code technologies to advance clinical research, announced today that industry veteran Brian Dufrense has joined the company as Senior Vice President, Business Development.
PharmaJet Announces Addition of Paul LaBarre as VP Global Business Development
BioTech 365
JUNE 15, 2021
PharmaJet Announces Addition of Paul LaBarre as VP Global Business Development PharmaJet Announces Addition of Paul LaBarre as VP Global Business Development Brings extensive global health experience to leadership team GOLDEN, Colo.–(BUSINESS
Oxford Finance Appoints David Hickman to Managing Director of Business Development
BioTech 365
APRIL 29, 2021
Oxford Finance Appoints David Hickman to Managing Director of Business Development Oxford Finance Appoints David Hickman to Managing Director of Business Development David has been appointed to Debbie Baker’s position upon her retirement announcement ALEXANDRIA, Va.–(BUSINESS
Business Development During COVID19 Quarantine For Clinical Research Sites and Job Seekers
Clinical Trial Gurus
SEPTEMBER 28, 2020
Business development is an ongoing process for each clinical research site. This video is based on a webinar that provides some strategies for improving the number of study leads that sites receive. Once a study lead is obtained, each site is responsible for pursuing each lead until the site gets activated.
Teva Appoints Angus Grant, PhD, as EVP of Business Development
Pharmaceutical Commerce
JULY 28, 2023
The pharma and biotech exec will begin his role on Aug.
Aperio Poised for Strategic Growth; Appoints Eric Ross as Vice President of Business Development
BioTech 365
NOVEMBER 9, 2021
Aperio Poised for Strategic Growth; Appoints Eric Ross as Vice President of Business Development Aperio Poised for Strategic Growth; Appoints Eric Ross as Vice President of Business Development RESEARCH TRIANGLE PARK, N.C.–(BUSINESS
ERS Genomics Expands Team With Appointment of Jon Kratochvil as VP Business Development
BioTech 365
MARCH 1, 2021
ERS Genomics Expands Team With Appointment of Jon Kratochvil as VP Business Development ERS Genomics Expands Team With Appointment of Jon Kratochvil as VP Business Development Jon Kratochvil joins as Vice President for Business Development & Licensing for North America … Continue reading →
CAPAssurance, a Risk Purchasing Group, Names Mitch Temple as Vice President Business Development
BioTech 365
JULY 19, 2021
CAPAssurance, a Risk Purchasing Group, Names Mitch Temple as Vice President Business Development CAPAssurance, a Risk Purchasing Group, Names Mitch Temple as Vice President Business Development Cooperative of American Physicians, Inc.
Customer Success: API and CDMO Business Development
Drug Patent Watch
DECEMBER 3, 2019
The post Customer Success: API and CDMO Business Development appeared first on DrugPatentWatch - Make Better Decisions. Changes in drug markets can create growth opportunities for API manufacturers and CDMOs alike. Whether change comes from generic entry, from new formulations of drugs, or from competition from novel….
Mainz Biomed Appoints Michele Pedrocchi, Former Head of Roche Diagnostics Business Development, to Strategic Advisory Board
BioTech 365
JANUARY 12, 2022
Mainz Biomed Appoints Michele Pedrocchi, Former Head of Roche Diagnostics Business Development, to Strategic Advisory Board Mainz Biomed Appoints Michele Pedrocchi, Former Head of Roche Diagnostics Business Development, to Strategic Advisory Board BERKELEY, Calif. and MAINZ, Germany, Jan.
Bioventus Appoints Chris Yamamoto Senior Vice President of Business Development and Strategy
BioTech 365
NOVEMBER 16, 2020
Bioventus Appoints Chris Yamamoto Senior Vice President of Business Development and Strategy Bioventus Appoints Chris Yamamoto Senior Vice President of Business Development and Strategy DURHAM, N.C.–(BUSINESS
Metrion Biosciences appoints Nick Foster as Chief Commercial Officer and Head of Global Business Development
BioTech 365
JULY 26, 2021
Metrion Biosciences appoints Nick Foster as Chief Commercial Officer and Head of Global Business Development Metrion Biosciences appoints Nick Foster as Chief Commercial Officer and Head of Global Business Development Appointment supports international growth within ion channel contract research and … Continue reading →
Steven C. Tomlin Named SVP of Business Development for Corizon
BioTech 365
OCTOBER 19, 2020
Tomlin has joined the company as Senior Vice President of Business Development, effective immediately. BRENTWOOD, Tenn., 19, 2020 (GLOBE NEWSWIRE) — Corizon Health announced today that longtime corrections treatment and healthcare executive Steven C. Tomlin, who most recently served … Continue reading →
Immunovant data show potential for autoimmune disease drug
Bio Pharma Dive
SEPTEMBER 26, 2023
Much anticipated clinical trial data for Immunovant’s experimental FcRn inhibitor could catalyze business development decisions for its parent, Roivant Sciences.
Clinical Trials 
278
278 Calyxt Appoints Sarah Reiter as Vice President of Business Development
BioTech 365
OCTOBER 14, 2020
Expanded leadership team will drive new business opportunities to support the company’s go-to-market strategies ROSEVILLE, Minn.–(BUSINESS –(BUSINESS WIRE)–Calyxt, Inc. NASDAQ: CLXT), a plant-based technology company, announced today that it has appointed Sarah Reiter as Vice President, Business Development.
PharmaJet Announces Addition of Melissa Malhame as VP Business Development
BioTech 365
SEPTEMBER 29, 2020
.–(BUSINESS WIRE)–PharmaJet®, the maker of innovative, needle-free injection technology, today announced that Melissa Malhame, has joined the leadership team as Vice President, Business Development. Malhame is … Continue reading →
Greenwich LifeSciences Hires Industry Expert Dr. Christine Fischette to Lead Business Development & Advise on Commercialization
BioTech 365
APRIL 19, 2021
Greenwich LifeSciences Hires Industry Expert Dr. Christine Fischette to Lead Business Development & Advise on Commercialization Greenwich LifeSciences Hires Industry Expert Dr. Christine Fischette to Lead Business Development & Advise on Commercialization Previously led partnering transactions and strategic analyses for … Continue reading (..)
Applied DNA Appoints Clay Shorrock as Chief Legal Officer and Executive Director of Business Development
BioTech 365
APRIL 1, 2021
Applied DNA Appoints Clay Shorrock as Chief Legal Officer and Executive Director of Business Development Applied DNA Appoints Clay Shorrock as Chief Legal Officer and Executive Director of Business Development – Shorrock Rejoins Company; Appointment Underscores Company’s Pursuit of Commercial … Continue reading →
MediClin AG: Business development to date shows an increasing capacity utilization in the clinics
BioTech 365
NOVEMBER 2, 2021
Business development to date shows an increasing capacity utilization in the clinics In the first nine months of … Continue reading → DGAP-News: MediClin AG / Key word(s): Quarter Results 02.11.2021 / 13:15 The issuer is solely responsible for the content of this announcement.
Rapid Dose Therapeutics Signs Agreement with AB Strategic Ventures for Business Development Advisory Services with First Nations Enterprises
BioTech 365
NOVEMBER 30, 2021
Rapid Dose Therapeutics Signs Agreement with AB Strategic Ventures for Business Development Advisory Services with First Nations Enterprises Rapid Dose Therapeutics Signs Agreement with AB Strategic Ventures for Business Development Advisory Services with First Nations Enterprises BURLINGTON, Ontario–(BUSINESS WIRE)–Rapid Dose … Continue (..)
InnoCare Appoints Dr. Manish Tandon as Vice President of Business Development
BioTech 365
OCTOBER 11, 2020
BEIJING–(BUSINESS WIRE)–InnoCare Pharma (HKEX: 09969), a clinical stage biopharmaceutical company, announced today that the Company has appointed Dr. Manish Tandon as Vice President of Business Development, reporting to the Co-founder, Chairman and CEO, Dr. Jasmine Cui.
Juice Pharma Introduces New EVP of Business Development
Pharmaceutical Commerce
JULY 20, 2023
Experienced exec joins the agency with over three decades of driving brand growth.
Ontario Bioscience Innovation Organization Secures Funding for Business Development Skills Program to Support Canadian Health Science Companies
BioTech 365
MAY 25, 2021
Ontario Bioscience Innovation Organization Secures Funding for Business Development Skills Program to Support Canadian Health Science Companies Ontario Bioscience Innovation Organization Secures Funding for Business Development Skills Program to Support Canadian Health Science Companies Innovative program will provide critical capabilities … (..)
BioMarin taps Amgen, Roche vets in executive reshuffle
Bio Pharma Dive
AUGUST 21, 2024
Greg Friberg and James Sabry will take over, respectively, as heads of R&D and business development, less than a year after BioMarin named a new CEO.
Biocontrol and Biostimulant Industry Leader Massimo Toni joins DunhamTrimmer as Vice President of New Business Development
BioTech 365
NOVEMBER 13, 2020
Biocontrol and Biostimulant Industry Leader Massimo Toni joins DunhamTrimmer as Vice President of New Business Development Biocontrol and Biostimulant Industry Leader Massimo Toni joins DunhamTrimmer as Vice President of New Business Development Bio intelligence leader gains 20 years experience in … Continue reading →
CytoDyn’s Chairman, CMO, and Head of Business Development Dr. Scott A. Kelly to Present at World Antiviral Congress 2021 Beginning Tomorrow
BioTech 365
NOVEMBER 29, 2021
CytoDyn’s Chairman, CMO, and Head of Business Development Dr. Scott A. Kelly to Present at World Antiviral Congress 2021 Beginning Tomorrow CytoDyn’s Chairman, CMO, and Head of Business Development Dr. Scott A. Kelly to Present at World Antiviral Congress 2021 … Continue reading →
PAOG Confirms CBD Nutraceuticals Business Development Update To Include ALKM, USMJ and PURA Highlights Scheduled This Wednesday, June 23rd
BioTech 365
JUNE 21, 2021
PAOG Confirms CBD Nutraceuticals Business Development Update To Include ALKM, USMJ and PURA Highlights Scheduled This Wednesday, June 23rd PAOG Confirms CBD Nutraceuticals Business Development Update To Include ALKM, USMJ and PURA Highlights Scheduled This Wednesday, June 23rd Sandusky, Ohio, … Continue reading →
Seres Therapeutics Announces David Arkowitz to Join as Executive Vice President, Chief Financial Officer and Head of Business Development
BioTech 365
MAY 20, 2021
Seres Therapeutics Announces David Arkowitz to Join as Executive Vice President, Chief Financial Officer and Head of Business Development Seres Therapeutics Announces David Arkowitz to Join as Executive Vice President, Chief Financial Officer and Head of Business Development CAMBRIDGE, Mass.–(BUSINESS
Medexus Appoints Michael Pine as Senior Vice President of Business Development and Strategy
BioTech 365
SEPTEMBER 25, 2020
the “Company” or “Medexus”) (TSXV: MDP, OTCQX: MEDXF), today announced the appointment of Michael Pine as Senior Vice President of Business Development and Strategy, effective September 21, 2020. MONTREAL, Sept. 25, 2020 (GLOBE NEWSWIRE) — Medexus Pharmaceuticals Inc.
Women In Bio Elects Katie Williams, Associate Director of Business Development at Applied BioMath, as 2021 President-Elect
BioTech 365
JANUARY 7, 2021
Women In Bio Elects Katie Williams, Associate Director of Business Development at Applied BioMath, as 2021 President-Elect Women In Bio Elects Katie Williams, Associate Director of Business Development at Applied BioMath, as 2021 President-Elect Sea Island, GA, Jan. 07, 2021 … Continue reading →
M1 Kliniken AG publishes figures for the 1st half of 2021: stable business development despite continued Corona burdens
BioTech 365
AUGUST 25, 2021
M1 Kliniken AG publishes figures for the 1st half of 2021: stable business development despite continued … Continue reading → DGAP-News: M1 Kliniken AG / Key word(s): Half Year Report/Miscellaneous 25.08.2021 / 14:30 The issuer is solely responsible for the content of this announcement.
MediClin AG: The effects of the coronavirus pandemic are burdening the business development in the first quarter of 2021
BioTech 365
MAY 3, 2021
The effects of the coronavirus pandemic are burdening the business development in the first quarter of … Continue reading → DGAP-News: MediClin AG / Key word(s): Quarterly / Interim Statement 03.05.2021 / 17:58 The issuer is solely responsible for the content of this announcement.
How Much Business Development Should Clinical Research Sites Be Doing
Clinical Trial Gurus
MARCH 19, 2021
Every site should have a strategy for finding new studies regardless of the current number of actively enrolling studies. Established sites tend to have a larger network that can help them find new studies based on the site’s reputation.
Drägerwerk AG & Co. KGaA: Business development in the first half year significantly above prior year despite lower earnings in the second quarter
BioTech 365
JULY 14, 2021
KGaA: Business development in the first half year significantly above prior year despite lower earnings in the second quarter 14-Jul-2021 / 19:29 CET/CEST Disclosure of … Continue reading → Drägerwerk AG & Co. KGaA / Key word(s): Half Year Results Drägerwerk AG & Co.
Business Development Is For Everyone In Clinical Research! Pharmacist Turned Entrepreneur Explains!
Clinical Trial Gurus
OCTOBER 5, 2021
Oftentimes as clinical research professionals we do not think of ourselves as sales people but expanding your opportunities in the life sciences industry is as important as anything else we will ever do for our careers.
Let's personalize your content